Suppr超能文献

口服脂肪酸补充剂对囊性纤维化患者汗液氯化物的负面影响。

Negative effects of oral fatty acid supplementation on sweat chloride in cystic fibrosis.

作者信息

Lloyd-Still J D, Simon S H, Wessel H U, Gibson L E

出版信息

Pediatrics. 1979 Jul;64(1):50-2.

PMID:450561
Abstract

Essential fatty acid supplementation with oral safflower oil (1 gm/kg/day) to 11 cystic fibrosis patients (aged 6 months to 14 years) for one year produced no significant change in sweat chloride concentration (mEq/liter) or sweat rate (gm/min/m2), Addition of vitamin E (10 mg/kg/day) to the safflower oil had no effect on sweat chloride concentration or rate compared to placebo. No clinical improvement could be detected compared to a control group. These results do not support previous reports of the effects of fatty acid supplementation on sweat electrolyte concentrations in cystic fibrosis.

摘要

对11名囊性纤维化患者(年龄在6个月至14岁之间)口服红花油(1克/千克/天)进行必需脂肪酸补充,为期一年,结果发现汗液氯化物浓度(毫当量/升)或出汗率(克/分钟/平方米)没有显著变化。与安慰剂相比,在红花油中添加维生素E(10毫克/千克/天)对汗液氯化物浓度或出汗率没有影响。与对照组相比,未检测到临床改善。这些结果不支持先前关于脂肪酸补充对囊性纤维化患者汗液电解质浓度影响的报道。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验